Abatacept retention and clinical outcomes in rheumatoid arthritis in clinical practice: comparison of the German cohort of the ACTION study with other participating countries

Background: ACTION (NCT02109666) was a 2-year, international, observational study of patients with moderate-to-severe RA who initiated IV abatacept in routine clinical practice. Previous findings showed discontinuation in biologic-naïve patients was higher in Germany versus other countries [ref:1].[for full text, please go to the a.m. URL]
46. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 32. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), Wissenschaftliche Herbsttagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR)